Quantitative Imaging for Evaluation of Response to Cancer Therapies (U01)
The summary for the Quantitative Imaging for Evaluation of Response to Cancer Therapies (U01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Quantitative Imaging for Evaluation of Response to Cancer Therapies (U01): This Funding Opportunity Announcement (FOA) invites research project - cooperative agreement (U01) applications which are expected to enhance the value of quantitative imaging (QI) in clinical trials for prediction and/or measurement of response to cancer therapies. One avenue for this enhancement is to emphasize the development, optimization and validation of state-of-the-art QI methods and software tools for potential implementation in single site phase 1 or 2 clinical trials. The second avenue to enhance QI methods is to address the challenges of integrating existing and or new QI methods as required for multicenter phase 3 clinical trials. This may involve evaluation of a range of multimodal imaging approaches, harmonization of image data collection, analysis, display and clinical workflow methods across imaging platforms, or testing their performance across different cancer sites.
Federal Grant Title: | Quantitative Imaging for Evaluation of Response to Cancer Therapies (U01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-14-116 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.394, 93.395 |
CFDA Descriptions: | Cancer Detection and Diagnosis Research; Cancer Treatment Research |
Current Application Deadline: | Feb 5, 2017 |
Original Application Deadline: | Feb 5, 2017 |
Posted Date: | Feb 26, 2014 |
Creation Date: | Feb 26, 2014 |
Archive Date: | Mar 8, 2017 |
Total Program Funding: | |
Maximum Federal Grant Award: | $500,000 |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
State governments
Independent school districts
Private institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Small businesses - Additional Information on Eligibility
- Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PAR-14-116.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatme...
- • Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate C...
- • Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Ca...
- • Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Ca...
- • Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologi...
- • Image-Guided Cancer Interventions (STTR [R41/R42])
- • An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44)
- • In Vivo Cancer Imaging Exploratory/Developmental Grants
- More Grants from the National Institutes of Health
- • Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Scie...
- • New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not All...
- • Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
- • Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- • Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)